Back to search

Article

Baveno VII Endoscopy-Sparing Criteria in MASLD- Predominant Compensated Cirrhosis: A Prospective Validation from a Gulf Arab Population (Kuwait)

2026-08-31

Abstract excerpt

<title>Abstract</title> <p>Background & Aims: The Baveno VII non-invasive criteria can safely defer screening endoscopy in compensated advanced chronic liver disease, but their performance in metabolic dysfunction-associated steatotic liver disease (MASLD), particularly with obesity, and in Gulf Arab populations is incompletely characterised. We validated the Baveno VII endoscopy-sparing criteria in a Kuwaiti, MA...

Identifiers and source

Literature Corpus work
a5eadeb6-d3c0-5a84-bca0-6a1701dec895
DOI
10.21203/rs.3.rs-10447678/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Baveno VII Endoscopy-Sparing Criteria in MASLD- Predominant Compensated Cirrhosis: A Prospective Validation from a Gulf Arab Population (Kuwait)DOI 10.21203/rs.3.rs-10447678/v1
Extracellular Vesicles as Biomarkers for Steatosis Stages in MASLD Patients: an Algorithmic Approach Using Explainable Artificial IntelligenceSemantic proximity
Extracellular Vesicles as Biomarkers for Steatosis Stages in MASLD Patients: an Algorithmic Approach Using Explainable Artificial IntelligenceSemantic proximity
Impact of Updated 2024 Diagnostic Criteria on Early Detection of Small-Duct PSC in Ulcerative Colitis Patients: A Clinical Mini-Review Focusing on Japanese StudiesSemantic proximity
Steatosis Non-Invasive Tests Accurately Predict Metabolic Dysfunction-Associated Steatotic Liver Disease, While Fibrosis Non-Invasive Tests Fall Short: Validation in U.S. Adult PopulationSemantic proximity
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitisSemantic proximity
Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control studySemantic proximity
Demographic, Clinical, and Laboratory Predictors of Liver Involvement in COVID-19 Patients with Gastrointestinal SymptomsSemantic proximity
Retrospective, Single-Center Analysis of Autoimmune Hepatitis in Yemeni Adults: Clinical Features and OutcomesSemantic proximity
FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “Semantic proximity
Prognostic Outcomes by Ishak Fibrosis Score Grouping in Biliary Atresia after Kasai Surgery: A Prospective StudySemantic proximity
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progressionSemantic proximity
Machine Learning–Based Prediction of Ultrasound-Detected Metabolic Dysfunction–Associated Steatotic Liver Disease Using Routine Clinical and Biochemical ParametersSemantic proximity
Select a neighboring publication to make it the new centre.